đź“Š Evidence-Based Reference
model ff d fx d pacemaker leads
Dr. Ing. P. Osypka
Summary: The model ff d fx d pacemaker leads by Dr. Ing. P. Osypka are FDA-cleared devices used in cardiac pacing. Key evidence includes 6 studies, though specific outcomes and safety data are not detailed in the provided evidence.
FDA Clearance Information
Pathway
510K
Number
K823896 ↗
Decision Date
April 30, 1983
Product Code
DTB
Device Class
Class 3
Evidence
0 studies
The device was cleared via the FDA 510(k) pathway on April 30, 1983, by Dr. Ing. P. Osypka. It is classified as a Class 3 device under product code DTB.
What It Is
The model ff d fx d pacemaker leads are designed for use in cardiac pacing, providing electrical stimulation to maintain heart rhythm. They are intended for patients requiring pacing due to arrhythmias or other cardiac conditions.
Clinical Applications
These pacemaker leads are commonly used in patients with bradycardia or heart block, where consistent cardiac pacing is necessary to maintain adequate heart rate and rhythm.
Evidence Summary
The available literature includes 6 studies, though specific details on study types and outcomes are limited. The studies range from 2017 to 2025, indicating ongoing research interest.
Reported Outcomes
Published studies report limited specific outcomes related to the pacemaker leads. The evidence provided does not detail efficacy findings directly related to the device.
Safety Profile
Reported complications include limited safety data specific to the pacemaker leads. The evidence provided does not detail adverse events directly related to the device.
Evidence Limitations
The evidence lacks specific data on the efficacy and safety of the pacemaker leads. Further research is needed to provide comprehensive outcomes and safety profiles.
Frequently Asked Questions
What are the clinical indications for model ff d fx d pacemaker leads?
Clinical indications are detailed in the FDA documentation, typically involving cardiac pacing needs.
What outcomes have been reported in clinical studies?
Specific outcomes related to the pacemaker leads are not detailed in the provided evidence.
What complications have been reported?
Safety data specific to the pacemaker leads is limited in the provided evidence.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.